ZS Pharma (ZSPH) Posts Q2 Loss of $4.72/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts ZSPH Hot Sheet
Join SI Premium – FREE
ZS Pharma (NASDAQ: ZSPH) reported Q2 EPS of ($4.72), $4.06 worse than the analyst estimate of ($0.66).
For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- StubHub Holdings (STUB) PT Lowered to $11 at Goldman Sachs
- Humana leads Managed Care winners in new CMS Star Ratings - Evercore
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
